Skip to main content

Table 1 Characteristics of the indicated groups

From: Irisin alleviates obesity-related spermatogenesis dysfunction via the regulation of the AMPKα signalling pathway

Group

Sample size (n)

Age (years)

BMI (kg/m2)

Sperm count (*106)

Progressive motility (%)

Testosterone (ng/mL)

FSH (mIU/mL)

LH (mIU/mL)

Control

10

27.9 ± 0.9

20.92 ± 0.45

61.04 ± 1.15

33.29 ± 1.97

4.18 ± 0.15

4.72 ± 0.24

3.68 ± 0.19

Obesity

9

28.9 ± 2.1

32.42 ± 0.46*

41.18 ± 1.28*

15.53 ± 0.83*

2.79 ± 0.12*

4.95 ± 0.23

3.37 ± 0.14

  1. Date are expressed as the mean ± SEM
  2. *p < 0.05, vs. Control group